Glaucoma: Diagnosis and Management

Dear Colleagues,

Glaucoma, a progressive eye disease affecting the optic nerve, is a leading cause of irreversible blindness worldwide. It often develops slowly and without noticeable symptoms until significant vision loss occurs. Diagnosis typically involves measuring intraocular pressure, assessing optic nerve head morphology, and visual field testing.

The management of glaucoma aims to reduce intraocular pressure to prevent further damage to the optic nerve and preserve vision. Treatment options include prescription eye drops, laser therapy such as selective laser trabeculoplasty (SLT), and surgical procedures like microinvasive glaucoma surgery (MIGS), minimally invasive bleb surgery (MIBS), trabeculectomy, or drainage implants.

Regular monitoring and adherence to treatment plans are essential for managing glaucoma effectively. Early detection through routine eye exams is key in initiating timely intervention to slow disease progression and maintain visual function. By raising awareness about the importance of regular eye screenings and adhering to treatment regimens, individuals can take proactive steps to preserve their vision and quality of life.

In this Special Issue, we invite contributions that discuss new technologies, emerging service models, and insights into current and future surgical procedures. Original articles, reviews, and reports are welcome to contribute to this discussion.

Dr. Chiara Posarelli
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• glaucoma
• adherence
• MIBS (minimally invasive bleb surgery)
• MIGS (microinvasive glaucoma surgery)
• artificial intelligence